GENINUS Inc. (KOSDAQ: 389030)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,422.00
+16.00 (1.14%)
Sep 12, 2024, 11:13 AM KST
-73.52%
Market Cap 46.89B
Revenue (ttm) 6.40B
Net Income (ttm) -12.65B
Shares Out 33.35M
EPS (ttm) -380.35
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 35,242
Open 1,406.00
Previous Close 1,406.00
Day's Range 1,406.00 - 1,448.00
52-Week Range 1,209.00 - 5,530.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 14, 2024

About GENINUS

GENINUS Inc., a bioinformation analysis company, engages in the research and development, manufacture, and sale of next generation sequencing (NGS) - based genome analysis solutions in South Korea. It offers CancerSCAN, an NGS-based cancer genome diagnosis solution; LiquidSCAN, a liquid biopsy NGS test; and Celinus, a single-cell analysis solution for ultra-precise genome analysis. The company also provides HealthSCAN, a genetic test service; WithMe, a service that analyzes gut bacteria characteristics related to the risk of chronic diseases; a... [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 2018
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.